BPG is committed to discovery and dissemination of knowledge
Cited by in F6Publishing
For: Choi BI, Kim HC, Han JK, Park JH, Kim YI, Kim ST, Lee HS, Kim CY, Han MC. Therapeutic effect of transcatheter oily chemoembolization therapy for encapsulated nodular hepatocellular carcinoma: CT and pathologic findings. Radiology 1992;182:709-13. [DOI: 10.1148/radiology.182.3.1311116] [Cited by in Crossref: 129] [Cited by in F6Publishing: 115] [Article Influence: 4.4] [Reference Citation Analysis]
Number Citing Articles
1 Park C, Gwon DI, Chu HH, Kim JW, Kim JH, Ko GY. Correlation of tumor response on CT with pathologically proven necrosis in hepatocellular carcinoma treated by conventional transcatheter arterial chemoembolization: threshold value of intratumoral Lipiodol accumulation predicting tumor necrosis. Abdom Radiol (NY) 2021;46:3729-37. [PMID: 33141259 DOI: 10.1007/s00261-020-02845-4] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
2 Baba Y, Hayashi S, Ueno K, Nakajo M, Ueno S, Kubo F, Baba Y, Hamanoue M, Hasegawa S, Tsubouchi H, Komorizono Y. Comparison of survival rates between patients treated with transcatheter arterial chemoembolization and hepatic resection for solitary hepatocellular carcinoma. Oncol Lett 2010;1:905-11. [PMID: 22966404 DOI: 10.3892/ol_00000161] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.1] [Reference Citation Analysis]
3 Herber S, Otto G, Schneider J, Manzl N, Kummer I, Kanzler S, Schuchmann A, Thies J, Düber C, Pitton M. Transarterial chemoembolization (TACE) for inoperable intrahepatic cholangiocarcinoma. Cardiovasc Intervent Radiol 2007;30:1156-65. [PMID: 17508242 DOI: 10.1007/s00270-007-9032-7] [Cited by in Crossref: 62] [Cited by in F6Publishing: 56] [Article Influence: 4.4] [Reference Citation Analysis]
4 Moon WK, Choi BI, Han JK, Kim SH, Chung JW, Park JH, Han MC. Iodized-oil retention within hepatic hemangioma: characteristics on iodized-oil CT. Abdom Imaging. 1996;21:420-426. [PMID: 8832863 DOI: 10.1007/s002619900096] [Cited by in Crossref: 3] [Cited by in F6Publishing: 1] [Article Influence: 0.1] [Reference Citation Analysis]
5 Shim JH, Lee HC, Kim SO, Shin YM, Kim KM, Lim YS, Suh DJ. Which response criteria best help predict survival of patients with hepatocellular carcinoma following chemoembolization? A validation study of old and new models. Radiology. 2012;262:708-718. [PMID: 22187634 DOI: 10.1148/radiol.11110282] [Cited by in Crossref: 186] [Cited by in F6Publishing: 166] [Article Influence: 18.6] [Reference Citation Analysis]
6 Lee DH, Lee JM, Klotz E, Kim SJ, Kim KW, Han JK, Choi BI. Detection of recurrent hepatocellular carcinoma in cirrhotic liver after transcatheter arterial chemoembolization: value of quantitative color mapping of the arterial enhancement fraction of the liver. Korean J Radiol 2013;14:51-60. [PMID: 23323031 DOI: 10.3348/kjr.2013.14.1.51] [Cited by in Crossref: 12] [Cited by in F6Publishing: 8] [Article Influence: 1.3] [Reference Citation Analysis]
7 Monsky WL, Kim I, Loh S, Li CS, Greasby TA, Deutsch LS, Badawi RD. Semiautomated segmentation for volumetric analysis of intratumoral ethiodol uptake and subsequent tumor necrosis after chemoembolization. AJR Am J Roentgenol 2010;195:1220-30. [PMID: 20966331 DOI: 10.2214/AJR.09.3964] [Cited by in Crossref: 41] [Cited by in F6Publishing: 23] [Article Influence: 3.7] [Reference Citation Analysis]
8 Shim JH, Han S, Shin YM, Yu E, Park W, Kim KM, Lim YS, Lee HC. Optimal measurement modality and method for evaluation of responses to transarterial chemoembolization of hepatocellular carcinoma based on enhancement criteria. J Vasc Interv Radiol 2013;24:316-25. [PMID: 23312990 DOI: 10.1016/j.jvir.2012.10.022] [Cited by in Crossref: 27] [Cited by in F6Publishing: 22] [Article Influence: 3.4] [Reference Citation Analysis]
9 Takayasu K, Arii S, Matsuo N, Yoshikawa M, Ryu M, Takasaki K, Sato M, Yamanaka N, Shimamura Y, Ohto M. Comparison of CT findings with resected specimens after chemoembolization with iodized oil for hepatocellular carcinoma. AJR Am J Roentgenol. 2000;175:699-704. [PMID: 10954453 DOI: 10.2214/ajr.175.3.1750699] [Cited by in Crossref: 162] [Cited by in F6Publishing: 143] [Article Influence: 7.7] [Reference Citation Analysis]
10 Jang KM, Choi D, Lim HK, Lim JH, Lee JY, Lee WJ, Kim SH, Lee SJ, Jeon YH, Lee J, Kim MJ, Shin SW, Park CK. Depiction of viable tumor in hepatocellular carcinoma treated with transarterial chemoembolization: multiphasic helical CT with review of the previous serial CT images. Korean J Radiol 2005;6:153-60. [PMID: 16145290 DOI: 10.3348/kjr.2005.6.3.153] [Cited by in Crossref: 13] [Cited by in F6Publishing: 11] [Article Influence: 0.9] [Reference Citation Analysis]
11 Choi J. Regional Transcatheter Therapy of Hepatic Neoplasms. Cancer Control 1996;3:407-13. [PMID: 10764498 DOI: 10.1177/107327489600300502] [Cited by in F6Publishing: 1] [Reference Citation Analysis]
12 Luo BM, Wen YL, Yang HY, Zhi H, Xiao XY, Ou B, Pan JS, Ma JH. Percutaneous ethanol injection, radiofrequency and their combination in treatment of hepatocellular carcinoma. World J Gastroenterol 2005;11:6277-80. [PMID: 16419155 DOI: 10.3748/wjg.v11.i40.6277] [Cited by in CrossRef: 16] [Cited by in F6Publishing: 16] [Article Influence: 1.1] [Reference Citation Analysis]
13 Monsky WL, Garza AS, Kim I, Loh S, Lin TC, Li CS, Fisher J, Sandhu P, Sidhar V, Chaudhari AJ. Treatment planning and volumetric response assessment for Yttrium-90 radioembolization: semiautomated determination of liver volume and volume of tumor necrosis in patients with hepatic malignancy. Cardiovasc Intervent Radiol. 2011;34:306-318. [PMID: 20683722 DOI: 10.1007/s00270-010-9938-3] [Cited by in Crossref: 22] [Cited by in F6Publishing: 18] [Article Influence: 2.0] [Reference Citation Analysis]
14 Li C, Chao Y, Chen L, Lee R, Lee W, Yuan J, Yen S, Lee S. Fever after transcatheter arterial chemoembolization for hepatocellular carcinoma: incidence and risk factor analysis. Scandinavian Journal of Gastroenterology 2009;43:992-9. [DOI: 10.1080/00365520801971744] [Cited by in Crossref: 16] [Cited by in F6Publishing: 12] [Article Influence: 1.3] [Reference Citation Analysis]
15 Hunt SJ, Yu W, Weintraub J, Prince MR, Kothary N. Radiologic Monitoring of Hepatocellular Carcinoma Tumor Viability after Transhepatic Arterial Chemoembolization: Estimating the Accuracy of Contrast-enhanced Cross-sectional Imaging with Histopathologic Correlation. Journal of Vascular and Interventional Radiology 2009;20:30-8. [DOI: 10.1016/j.jvir.2008.09.034] [Cited by in Crossref: 47] [Cited by in F6Publishing: 34] [Article Influence: 3.9] [Reference Citation Analysis]
16 Miraglia R, Pietrosi G, Maruzzelli L, Petridis I, Caruso S, Marrone G, Mamone G, Vizzini G, Luca A, Gridelli B. Predictive factors of tumor response to trans-catheter treatment in cirrhotic patients with hepatocellular carcinoma: a multivariate analysis of pre-treatment findings. World J Gastroenterol 2007;13:6022-6. [PMID: 18023093 DOI: 10.3748/wjg.v13.45.6022] [Cited by in CrossRef: 7] [Cited by in F6Publishing: 8] [Article Influence: 0.5] [Reference Citation Analysis]
17 Takayasu K, Muramatsu Y, Maeda T, Iwata R, Furukawa H, Muramatsu Y, Moriyama N, Okusaka T, Okada S, Ueno H. Targeted transarterial oily chemoembolization for small foci of hepatocellular carcinoma using a unified helical CT and angiography system: analysis of factors affecting local recurrence and survival rates. AJR Am J Roentgenol. 2001;176:681-688. [PMID: 11222205 DOI: 10.2214/ajr.176.3.1760681] [Cited by in Crossref: 121] [Cited by in F6Publishing: 109] [Article Influence: 6.1] [Reference Citation Analysis]
18 Kim YS, Rhim H, Lim HK, Park CK, Lee WJ, Do YS, Cho JW. Completeness of treatment in hepatocellular carcinomas treated with image-guided tumor therapies: Evaluation of positive predictive value of contrast-enhanced CT with histopathologic correlation in the explanted liver specimen. J Comput Assist Tomogr. 2006;30:578-582. [PMID: 16845287 DOI: 10.1097/00004728-200607000-00005] [Cited by in Crossref: 20] [Cited by in F6Publishing: 21] [Article Influence: 1.3] [Reference Citation Analysis]
19 Chen R, Geschwind JF, Wang Z, Tacher V, Lin M. Quantitative assessment of lipiodol deposition after chemoembolization: comparison between cone-beam CT and multidetector CT. J Vasc Interv Radiol 2013;24:1837-44. [PMID: 24094672 DOI: 10.1016/j.jvir.2013.08.017] [Cited by in Crossref: 27] [Cited by in F6Publishing: 20] [Article Influence: 3.4] [Reference Citation Analysis]
20 Kisaka Y, Hirooka M, Kumagi T, Uehara T, Hiasa Y, Kumano S, Tanaka H, Michitaka K, Horiike N, Mochizuki T, Onji M. Usefulness of contrast-enhanced ultrasonography with abdominal virtual ultrasonography in assessing therapeutic response in hepatocellular carcinoma treated with radiofrequency ablation. Liver Int 2006;26:1241-7. [DOI: 10.1111/j.1478-3231.2006.01367.x] [Cited by in Crossref: 31] [Cited by in F6Publishing: 24] [Article Influence: 2.1] [Reference Citation Analysis]
21 Ding H, Kudo M, Onda H, Suetomi Y, Minami Y, Maekawa K. Contrast-enhanced subtraction harmonic sonography for evaluating treatment response in patients with hepatocellular carcinoma. AJR Am J Roentgenol. 2001;176:661-666. [PMID: 11222201 DOI: 10.2214/ajr.176.3.1760661] [Cited by in Crossref: 62] [Cited by in F6Publishing: 54] [Article Influence: 3.1] [Reference Citation Analysis]
22 Padia SA, Alessio A, Kwan SW, Lewis DH, Vaidya S, Minoshima S. Comparison of positron emission tomography and bremsstrahlung imaging to detect particle distribution in patients undergoing yttrium-90 radioembolization for large hepatocellular carcinomas or associated portal vein thrombosis. J Vasc Interv Radiol 2013;24:1147-53. [PMID: 23792126 DOI: 10.1016/j.jvir.2013.04.018] [Cited by in Crossref: 29] [Cited by in F6Publishing: 27] [Article Influence: 3.6] [Reference Citation Analysis]
23 Shin SW, Do YS, Choo SW, Lieu WC, Cho SK, Park KB, Yoo BC, Kang EH, Choo I. Diaphragmatic Weakness after Transcatheter Arterial Chemoembolization of Inferior Phrenic Artery for Treatment of Hepatocellular Carcinoma. Radiology 2006;241:581-8. [DOI: 10.1148/radiol.2412051209] [Cited by in Crossref: 17] [Cited by in F6Publishing: 11] [Article Influence: 1.1] [Reference Citation Analysis]
24 Hayashi K, Ina H, Tezuka M, Okada Y, Irie T. Local therapeutic results of computed tomography-guided transcatheter arterial chemoembolization for hepatocellular carcinoma: results of 265 tumors in 79 patients. Cardiovasc Intervent Radiol. 2007;30:1144-1155. [PMID: 17909884 DOI: 10.1007/s00270-007-9169-4] [Cited by in Crossref: 20] [Cited by in F6Publishing: 19] [Article Influence: 1.4] [Reference Citation Analysis]
25 Wu F, Wang ZB, Chen WZ, Zou JZ, Bai J, Zhu H, Li KQ, Jin CB, Xie FL, Su HB. Advanced hepatocellular carcinoma: treatment with high-intensity focused ultrasound ablation combined with transcatheter arterial embolization. Radiology. 2005;235:659-667. [PMID: 15858105 DOI: 10.1148/radiol.2352030916] [Cited by in Crossref: 167] [Cited by in F6Publishing: 136] [Article Influence: 10.4] [Reference Citation Analysis]
26 Zurera L, Canis M, Marchal T, García-revillo J, Martos J, Benito A, Fraga E. Estudio histopatológico del efecto de la quimioembolización pretrasplante en el hepatocarcinoma. Radiología 2008;50:47-53. [DOI: 10.1016/s0033-8338(08)71928-3] [Cited by in Crossref: 3] [Article Influence: 0.2] [Reference Citation Analysis]
27 Kang HJ, Lee JM, Jeon SK, Ryu H, Yoo J, Lee JK, Han JK. Microvascular Flow Imaging of Residual or Recurrent Hepatocellular Carcinoma after Transarterial Chemoembolization: Comparison with Color/Power Doppler Imaging.Korean J Radiol. 2019;20:1114-1123. [PMID: 31270975 DOI: 10.3348/kjr.2018.0932] [Cited by in Crossref: 6] [Cited by in F6Publishing: 3] [Article Influence: 6.0] [Reference Citation Analysis]
28 Lee DH, Lee JM, Lee JY, Kim SH, Han JK, Choi BI. Radiofrequency ablation for intrahepatic recurrent hepatocellular carcinoma: long-term results and prognostic factors in 168 patients with cirrhosis. Cardiovasc Intervent Radiol 2014;37:705-15. [PMID: 23912493 DOI: 10.1007/s00270-013-0708-x] [Cited by in Crossref: 21] [Cited by in F6Publishing: 23] [Article Influence: 2.6] [Reference Citation Analysis]
29 Cho YZ, Park SY, Choi EH, Baik SK, Kwon SO, Kim YJ, Cha SH, Kim MY. The usefulness of contrast-enhanced ultrasonography in the early detection of hepatocellular carcinoma viability after transarterial chemoembolization: pilot study. Clin Mol Hepatol 2015;21:165-74. [PMID: 26157754 DOI: 10.3350/cmh.2015.21.2.165] [Cited by in Crossref: 12] [Cited by in F6Publishing: 10] [Article Influence: 2.0] [Reference Citation Analysis]
30 Chung JW. Recent advance in international management of hepatocellular carcinoma. J Korean Med Assoc 2013;56:972. [DOI: 10.5124/jkma.2013.56.11.972] [Cited by in Crossref: 3] [Cited by in F6Publishing: 2] [Article Influence: 0.4] [Reference Citation Analysis]
31 Yang Z, Zou R, Zheng Y, Qiu J, Shen J, Liao Y, Zhang Y, Wang C, Wang Y, Yuan Y, Li K, Zuo D, He W, Liu W, Li B, Yuan Y. Lipiodol deposition in portal vein tumour thrombus predicts treatment outcome in HCC patients after transarterial chemoembolisation. Eur Radiol 2019;29:5752-62. [PMID: 30993438 DOI: 10.1007/s00330-019-06157-0] [Cited by in Crossref: 8] [Cited by in F6Publishing: 4] [Article Influence: 4.0] [Reference Citation Analysis]
32 Youk JH, Lee JM, Kim CS. Therapeutic response evaluation of malignant hepatic masses treated by interventional procedures with contrast-enhanced agent detection imaging. J Ultrasound Med 2003;22:911-20. [PMID: 14510262 DOI: 10.7863/jum.2003.22.9.911] [Cited by in Crossref: 28] [Cited by in F6Publishing: 20] [Article Influence: 1.6] [Reference Citation Analysis]
33 Brown DB, Gould JE, Gervais DA, Goldberg SN, Murthy R, Millward SF, Rilling WS, Geschwind JF, Salem R, Vedantham S. Transcatheter therapy for hepatic malignancy: standardization of terminology and reporting criteria. J Vasc Interv Radiol. 2007;18:1469-1478. [PMID: 18057279 DOI: 10.1016/j.jvir.2007.08.027] [Cited by in Crossref: 51] [Cited by in F6Publishing: 49] [Article Influence: 3.9] [Reference Citation Analysis]
34 Wen YL, Kudo M, Minami Y, Chung H, Suetomi Y, Onda H, Kitano M, Kawasaki T, Maekawa K. Detection of tumor vascularity in hepatocellular carcinoma with contrast-enhanced Dynamic Flow imaging: Comparison with contrast-enhanced power Doppler imaging. J Med Ultrason (2001) 2003;30:141-51. [PMID: 27278304 DOI: 10.1007/BF02481219] [Cited by in Crossref: 7] [Cited by in F6Publishing: 2] [Article Influence: 1.4] [Reference Citation Analysis]
35 Hu J, Maybody M, Cao G, Wang X, Chen H, Zhu X, Yang R, Wang X. Lipiodol retention pattern assessed by cone beam computed tomography during conventional transarterial chemoembolization of hepatocellular carcinoma: accuracy and correlation with response. Cancer Imaging. 2016;16:32. [PMID: 27716376 DOI: 10.1186/s40644-016-0090-4] [Cited by in Crossref: 7] [Cited by in F6Publishing: 7] [Article Influence: 1.4] [Reference Citation Analysis]
36 Kisaka Y, Hirooka M, Koizumi Y, Abe M, Matsuura B, Hiasa Y, Onji M. Contrast-enhanced sonography with abdominal virtual sonography in monitoring radiofrequency ablation of hepatocellular carcinoma. J Clin Ultrasound. 2010;38:138-144. [PMID: 20014137 DOI: 10.1002/jcu.20654] [Cited by in F6Publishing: 3] [Reference Citation Analysis]
37 Jiang ZX, Peng WJ, Li WT, Tang F, Liu SY, Qu XD, Wang JH, Lu HF. Effect of b value on monitoring therapeutic response by diffusion-weighted imaging. World J Gastroenterol. 2008;14:5893-5899. [PMID: 18855990 DOI: 10.3748/wjg.14.5893] [Cited by in CrossRef: 10] [Cited by in F6Publishing: 9] [Article Influence: 0.8] [Reference Citation Analysis]
38 Liu M, Lin M, Lu M, Xu Z, Zheng K, Wang W, Kuang M, Zhuang W, Xie X. Comparison of contrast-enhanced ultrasound and contrast-enhanced computed tomography in evaluating the treatment response to transcatheter arterial chemoembolization of hepatocellular carcinoma using modified RECIST. Eur Radiol 2015;25:2502-11. [DOI: 10.1007/s00330-015-3611-9] [Cited by in Crossref: 25] [Cited by in F6Publishing: 19] [Article Influence: 4.2] [Reference Citation Analysis]
39 Buijs M, Kamel IR, Vossen JA, Georgiades CS, Hong K, Geschwind JF. Assessment of metastatic breast cancer response to chemoembolization with contrast agent enhanced and diffusion-weighted MR imaging. J Vasc Interv Radiol. 2007;18:957-963. [PMID: 17675611 DOI: 10.1016/j.jvir.2007.04.025] [Cited by in Crossref: 51] [Cited by in F6Publishing: 44] [Article Influence: 3.9] [Reference Citation Analysis]
40 Jeon UB, Lee JW, Choo KS, Kim CW, Kim S, Lee TH, Jeong YJ, Kang DH. Iodized oil uptake assessment with cone-beam CT in chemoembolization of small hepatocellular carcinomas. World J Gastroenterol 2009;15:5833-7. [PMID: 19998505 DOI: 10.3748/wjg.15.5833] [Cited by in CrossRef: 23] [Cited by in F6Publishing: 20] [Article Influence: 2.1] [Reference Citation Analysis]
41 Hu B, Zhong BY, Zhang L, Dai C, Li W, Shen J, Huang P, Zhang S, Li Z, Ni CF. Occurrence of Vascular Lake Phenomenon Before Embolization for the Prediction of Lipiodol Uptake for Intermediate-Stage Hepatocellular Carcinoma Patients that Underwent cTACE. Cardiovasc Intervent Radiol 2020;43:1460-7. [PMID: 32500251 DOI: 10.1007/s00270-020-02501-w] [Cited by in Crossref: 2] [Cited by in F6Publishing: 1] [Article Influence: 2.0] [Reference Citation Analysis]
42 Ding H, Kudo M, Onda H, Suetomi Y, Minami Y, Chung H, Kawasaki T, Maekawa K. Evaluation of posttreatment response of hepatocellular carcinoma with contrast-enhanced coded phase-inversion harmonic US: comparison with dynamic CT. Radiology. 2001;221:721-730. [PMID: 11719668 DOI: 10.1148/radiol.2213010358] [Cited by in Crossref: 102] [Cited by in F6Publishing: 88] [Article Influence: 5.1] [Reference Citation Analysis]
43 Lang EK. Reduced systemic toxicity from superselective chemoembolization compared with systemic chemotherapy in patients with high-risk metastatic gestational trophoblastic disease. Cardiovasc Intervent Radiol 1997;20:280-4. [DOI: 10.1007/s002709900152] [Cited by in Crossref: 21] [Cited by in F6Publishing: 14] [Article Influence: 0.9] [Reference Citation Analysis]
44 Lee DH, Chung JW, Kim H, Jae HJ, Yoon CJ, Kang SG, Jeon UB, So YH, Yin YH, Park JH. Development of Diaphragmatic Weakness after Transcatheter Arterial Chemoembolization of the Right Inferior Phrenic Artery: Frequency and Determinant Factors. Journal of Vascular and Interventional Radiology 2009;20:484-9. [DOI: 10.1016/j.jvir.2008.11.023] [Cited by in Crossref: 9] [Cited by in F6Publishing: 5] [Article Influence: 0.8] [Reference Citation Analysis]
45 Wang X, Erinjeri JP, Jia X, Gonen M, Brown KT, Sofocleous CT, Getrajdman GI, Brody LA, Thornton RH, Maybody M, Covey AM, Siegelbaum RH, Alago W, Solomon SB. Pattern of retained contrast on immediate postprocedure computed tomography (CT) after particle embolization of liver tumors predicts subsequent treatment response. Cardiovasc Intervent Radiol. 2013;36:1030-1038. [PMID: 23152036 DOI: 10.1007/s00270-012-0506-x] [Cited by in Crossref: 26] [Cited by in F6Publishing: 20] [Article Influence: 2.9] [Reference Citation Analysis]
46 Shim JH, Lee HC, Won HJ, Shin YM, Kim KM, Lim YS, Suh DJ. Maximum number of target lesions required to measure responses to transarterial chemoembolization using the enhancement criteria in patients with intrahepatic hepatocellular carcinoma. J Hepatol. 2012;56:406-411. [PMID: 21782761 DOI: 10.1016/j.jhep.2011.04.028] [Cited by in Crossref: 28] [Cited by in F6Publishing: 28] [Article Influence: 2.8] [Reference Citation Analysis]
47 Murakami T, Nakamura H, Hori S, Tomoda K, Mitani T, Nakanishi K, Hashimoto T, Tsuda K, Kozuka T, Monden M, Wakasa K. Detection of Viable Tumor Cells in Hepatocellular Carcinoma following Transcatheter Arterial Chemoembolization with Iodized Oil: Pathologic Correlation with Dynamic Turbo-Flash MR Imaging with Gd-DTPA. Acta Radiol 1993;34:399-403. [DOI: 10.1177/028418519303400419] [Cited by in Crossref: 24] [Cited by in F6Publishing: 19] [Article Influence: 4.8] [Reference Citation Analysis]
48 Molinari M, Kachura JR, Dixon E, Rajan DK, Hayeems EB, Asch MR, Benjamin MS, Sherman M, Gallinger S, Burnett B. Transarterial chemoembolisation for advanced hepatocellular carcinoma: results from a North American cancer centre. Clin Oncol (R Coll Radiol). 2006;18:684-692. [PMID: 17100154 DOI: 10.1016/j.clon.2006.07.012] [Cited by in Crossref: 27] [Cited by in F6Publishing: 29] [Article Influence: 1.9] [Reference Citation Analysis]
49 Suh SH, Won JY, Lee DY, Lee JT, Lee K. Chemoembolization of the Left Inferior Phrenic Artery in Patients with Hepatocellular Carcinoma: Radiographic Findings and Clinical Outcome. Journal of Vascular and Interventional Radiology 2005;16:1741-5. [DOI: 10.1097/01.rvi.0000182172.00168.1b] [Cited by in Crossref: 17] [Cited by in F6Publishing: 3] [Article Influence: 1.1] [Reference Citation Analysis]
50 Lee JY, Kim Y, Rhim H, Lim HK, Choi D, Lee WJ. Pattern and Chronological Change of Iodized Oil Retention in Radiofrequency Ablation-Induced Vascular Injury Area: Differentiation From Iodized Oil Retention in Recurrent Hepatocellular Carcinoma on Computed Tomography. Journal of Computer Assisted Tomography 2010;34:354-61. [DOI: 10.1097/rct.0b013e3181cbf43a] [Cited by in Crossref: 1] [Article Influence: 0.1] [Reference Citation Analysis]
51 Han YM, Park HH, Lee JM, Kim JC, Hwang PH, Lee DK, Kim CS, Choi KC. Effectiveness of preoperative transarterial chemoembolization in presumed inoperable hepatoblastoma. J Vasc Interv Radiol. 1999;10:1275-1280. [PMID: 10527208 DOI: 10.1016/S1051-0443(99)70231-9] [Cited by in Crossref: 21] [Cited by in F6Publishing: 3] [Article Influence: 1.0] [Reference Citation Analysis]
52 Kamel IR, Bluemke DA, Eng J, Liapi E, Messersmith W, Reyes DK, Geschwind JF. The role of functional MR imaging in the assessment of tumor response after chemoembolization in patients with hepatocellular carcinoma. J Vasc Interv Radiol. 2006;17:505-512. [PMID: 16567675 DOI: 10.1097/01.rvi.0000200052.02183.92] [Cited by in Crossref: 152] [Cited by in F6Publishing: 48] [Article Influence: 10.1] [Reference Citation Analysis]
53 Nakagawa N, Cornelius AS, Kao SC, Nakajima Y, Nakada K. Transcatheter Oily Chemoembolization for Unresectable Malignant Liver Tumors in Children. Journal of Vascular and Interventional Radiology 1993;4:353-8. [DOI: 10.1016/s1051-0443(93)71875-8] [Cited by in Crossref: 10] [Cited by in F6Publishing: 1] [Article Influence: 0.4] [Reference Citation Analysis]
54 Bolog N, Pfammatter T, Müllhaupt B, Andreisek G, Weishaupt D. Double-contrast magnetic resonance imaging of hepatocellular carcinoma after transarterial chemoembolization. Abdom Imaging. 2008;33:313-323. [PMID: 17483983 DOI: 10.1007/s00261-007-9244-y] [Cited by in Crossref: 9] [Cited by in F6Publishing: 7] [Article Influence: 0.7] [Reference Citation Analysis]
55 Saverio Ferrari F, Stella A, Pasquinucci P, Vigni F, Civeli L, Pieraccini M, Magnolfi F. Treatment of small hepatocellular carcinoma: a comparison of techniques and long-term results: . European Journal of Gastroenterology & Hepatology 2006;18:659-72. [DOI: 10.1097/00042737-200606000-00014] [Cited by in Crossref: 18] [Cited by in F6Publishing: 14] [Article Influence: 1.2] [Reference Citation Analysis]
56 Iwazawa J, Ohue S, Kitayama T, Sassa S, Mitani T. C-Arm CT for Assessing Initial Failure of Iodized Oil Accumulation in Chemoembolization of Hepatocellular Carcinoma. American Journal of Roentgenology 2011;197:W337-42. [DOI: 10.2214/ajr.10.5614] [Cited by in Crossref: 19] [Cited by in F6Publishing: 8] [Article Influence: 1.9] [Reference Citation Analysis]
57 Vogl TJ, Trapp M, Schroeder H, Mack M, Schuster A, Schmitt J, Neuhaus P, Felix R. Transarterial chemoembolization for hepatocellular carcinoma: volumetric and morphologic CT criteria for assessment of prognosis and therapeutic success-results from a liver transplantation center. Radiology. 2000;214:349-357. [PMID: 10671580 DOI: 10.1148/radiology.214.2.r00fe06349] [Cited by in Crossref: 125] [Cited by in F6Publishing: 100] [Article Influence: 6.0] [Reference Citation Analysis]
58 Mondazzi L, Bottelli R, Brambilla G, Rampoldi A, Rezakovic I, Zavaglia C, Alberti A, Idèo G. Transarterial oily chemoembolization for the treatment of hepatocellular carcinoma: a multivariate analysis of prognostic factors. Hepatology. 1994;19:1115-1123. [PMID: 7513677 DOI: 10.1002/hep.1840190508] [Cited by in Crossref: 128] [Cited by in F6Publishing: 83] [Article Influence: 4.7] [Reference Citation Analysis]
59 Bartolozzi C, Cioni D, Donati F, Granai G, Lencioni R. Imaging Evaluation of Tumor Response. In: Bartolozzi C, Lencioni R, editors. Liver Malignancies. Berlin: Springer Berlin Heidelberg; 1999. pp. 467-87. [DOI: 10.1007/978-3-642-58641-5_30] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 0.1] [Reference Citation Analysis]
60 Shim JH, Kim KM, Lee YJ, Ko GY, Yoon HK, Sung KB, Park KM, Lee SG, Lim YS, Lee HC. Complete necrosis after transarterial chemoembolization could predict prolonged survival in patients with recurrent intrahepatic hepatocellular carcinoma after curative resection. Ann Surg Oncol. 2010;17:869-877. [PMID: 20033326 DOI: 10.1245/s10434-009-0788-7] [Cited by in Crossref: 38] [Cited by in F6Publishing: 33] [Article Influence: 3.2] [Reference Citation Analysis]
61 Su YW, Huang YW, Chen SH, Tzen CY. Quantitative analysis of plasma HBV DNA for early evaluation of the response to transcatheter arterial embolization for HBV-related hepatocellular carcinoma. World J Gastroenterol 2005;11:6193-6. [PMID: 16273649 DOI: 10.3748/wjg.v11.i39.6193] [Cited by in CrossRef: 6] [Cited by in F6Publishing: 6] [Article Influence: 0.4] [Reference Citation Analysis]
62 Lopez Hänninen E, Vogl TJ, Bechstein WO, Guckelberger O, Neuhaus P, Lobeck H, Felix R. Biphasic spiral computed tomography for detection of hepatocellular carcinoma before resection or orthotopic liver transplantation. Invest Radiol 1998;33:216-21. [PMID: 9556746 DOI: 10.1097/00004424-199804000-00004] [Cited by in Crossref: 29] [Cited by in F6Publishing: 27] [Article Influence: 1.3] [Reference Citation Analysis]
63 Helmberger T, Hoffmann RT, Jakobs T, Leibecke T, Lubienski A, Reiser M. [Liver tumor ablation]. Radiologe. 2005;45:55-62. [PMID: 15609015 DOI: 10.1007/s00117-004-1149-y] [Cited by in Crossref: 3] [Cited by in F6Publishing: 2] [Article Influence: 0.3] [Reference Citation Analysis]
64 Park JH, Kim SH, Park HS, Kim GH, Lee JY, Lee JM, Han JK, Choi BI. Added value of 80 kVp images to averaged 120 kVp images in the detection of hepatocellular carcinomas in liver transplantation candidates using dual-source dual-energy MDCT: results of JAFROC analysis. Eur J Radiol 2011;80:e76-85. [PMID: 20875937 DOI: 10.1016/j.ejrad.2010.08.018] [Cited by in Crossref: 14] [Cited by in F6Publishing: 12] [Article Influence: 1.3] [Reference Citation Analysis]
65 Tellez C, Benson AB 3rd, Lyster MT, Talamonti M, Shaw J, Braun MA, Nemcek AA Jr, Vogelzang RL. Phase II trial of chemoembolization for the treatment of metastatic colorectal carcinoma to the liver and review of the literature. Cancer 1998;82:1250-9. [PMID: 9529016 DOI: 10.1002/(sici)1097-0142(19980401)82:7<1250::aid-cncr7>3.0.co;2-j] [Cited by in Crossref: 125] [Cited by in F6Publishing: 38] [Article Influence: 5.4] [Reference Citation Analysis]
66 Park YS, Lee CH, Kim JH, Kim IS, Kiefer B, Seo TS, Kim KA, Park CM. Using intravoxel incoherent motion (IVIM) MR imaging to predict lipiodol uptake in patients with hepatocellular carcinoma following transcatheter arterial chemoembolization: a preliminary result. MagnReson Imaging. 2014;32:638-646. [PMID: 24703575 DOI: 10.1016/j.mri.2014.03.003] [Cited by in Crossref: 31] [Cited by in F6Publishing: 26] [Article Influence: 4.4] [Reference Citation Analysis]
67 Yu SC, Hui JW, Hui EP, Mo F, Lee PS, Wong J, Lee KF, Lai PB, Yeo W. Embolization Efficacy and Treatment Effectiveness of Transarterial Therapy for Unresectable Hepatocellular Carcinoma: A Case-Controlled Comparison of Transarterial Ethanol Ablation with Lipiodol–Ethanol Mixture versus Transcatheter Arterial Chemoembolization. Journal of Vascular and Interventional Radiology 2009;20:352-9. [DOI: 10.1016/j.jvir.2008.12.407] [Cited by in Crossref: 22] [Cited by in F6Publishing: 19] [Article Influence: 1.8] [Reference Citation Analysis]
68 Maataoui A, Qian J, Vossoughi D, Khan MF, Oppermann E, Bechstein WO, Vogl TJ. Transarterial chemoembolization alone and in combination with other therapies: a comparative study in an animal HCC model. Eur Radiol 2005;15:127-33. [PMID: 15580507 DOI: 10.1007/s00330-004-2517-8] [Cited by in Crossref: 31] [Cited by in F6Publishing: 26] [Article Influence: 1.8] [Reference Citation Analysis]
69 Chung JW, Park JH, Han JK, Choi BI, Kim TK, Han MC. Transcatheter oily chemoembolization of the inferior phrenic artery in hepatocellular carcinoma: the safety and potential therapeutic role. J Vasc Interv Radiol 1998;9:495-500. [PMID: 9618112 DOI: 10.1016/s1051-0443(98)70306-9] [Cited by in Crossref: 91] [Cited by in F6Publishing: 10] [Article Influence: 4.0] [Reference Citation Analysis]
70 Jonczyk M, Collettini F, Geisel D, Schnapauff D, Böning G, Wieners G, Gebauer G. Radiation exposure during TACE procedures using additional cone-beam CT (CBCT) for guidance: safety and precautions. Acta Radiol 2018;59:1277-84. [DOI: 10.1177/0284185118761203] [Cited by in Crossref: 6] [Cited by in F6Publishing: 3] [Article Influence: 2.0] [Reference Citation Analysis]
71 Brown DB, Gould JE, Gervais DA, Goldberg SN, Murthy R, Millward SF, Rilling WS, Geschwind JF, Salem R, Vedantham S. Transcatheter therapy for hepatic malignancy: standardization of terminology and reporting criteria. J Vasc Interv Radiol. 2009;20:S425-S434. [PMID: 19560030 DOI: 10.1016/j.jvir.2009.04.021] [Cited by in Crossref: 86] [Cited by in F6Publishing: 71] [Article Influence: 7.2] [Reference Citation Analysis]
72 Palma LD. Diagnostic imaging and interventional therapy of hepatocellular carcinoma. Br J Radiol. 1998;71:808-818. [PMID: 9828792 DOI: 10.1259/bjr.71.848.9828792] [Cited by in Crossref: 35] [Cited by in F6Publishing: 30] [Article Influence: 1.5] [Reference Citation Analysis]
73 Maruyama M, Yoshizako T, Nakamura T, Nakamura M, Yoshida R, Kitagaki H. Initial Experience with Balloon-Occluded Trans-catheter Arterial Chemoembolization (B-TACE) for Hepatocellular Carcinoma. Cardiovasc Intervent Radiol. 2016;39:359-366. [PMID: 26711804 DOI: 10.1007/s00270-015-1237-6] [Cited by in Crossref: 16] [Cited by in F6Publishing: 13] [Article Influence: 2.7] [Reference Citation Analysis]
74 Yu JS. Hepatocellular carcinoma after transcatheter arterial chemoembolization: difficulties on imaging follow-up. Korean J Radiol 2005;6:134-5. [PMID: 16145287 DOI: 10.3348/kjr.2005.6.3.134] [Cited by in Crossref: 3] [Cited by in F6Publishing: 3] [Article Influence: 0.2] [Reference Citation Analysis]
75 Kobayashi S, Nakanuma Y, Matsui O. Histopathology of portal tracts in livers after transcatheter arterial chemo-embolization therapy for hepatocellular carcinoma. J Gastroenterol Hepatol 1994;9:45-54. [DOI: 10.1111/j.1440-1746.1994.tb01215.x] [Cited by in Crossref: 19] [Cited by in F6Publishing: 17] [Article Influence: 0.7] [Reference Citation Analysis]
76 Mizuki A, Tatemichi M, Tsukada N, Nagamatsu R, Kawaguchi M, Itoshima T, Maruyama S, Satou A, Imari Y, Kawatoko T. Addition of transcatheter arterial chemoembolization decreased local recurrence but had no survival benefit to percutaneous ethanol injection therapy for patients with small hepatocellular carcinoma: A multicenter randomized control study. Oncol Lett. 2010;1:855-859. [PMID: 22966394 DOI: 10.3892/ol_00000151] [Cited by in Crossref: 5] [Cited by in F6Publishing: 5] [Article Influence: 0.5] [Reference Citation Analysis]
77 Gaba RC, Lewandowski RJ, Hickey R, Baerlocher MO, Cohen EI, Dariushnia SR, Janne d'Othée B, Padia SA, Salem R, Wang DS, Nikolic B, Brown DB; Society of Interventional Radiology Technology Assessment Committee. Transcatheter Therapy for Hepatic Malignancy: Standardization of Terminology and Reporting Criteria. J Vasc Interv Radiol 2016;27:457-73. [PMID: 26851158 DOI: 10.1016/j.jvir.2015.12.752] [Cited by in Crossref: 67] [Cited by in F6Publishing: 49] [Article Influence: 13.4] [Reference Citation Analysis]
78 Solomon SB, Silverman SG. Imaging in interventional oncology. Radiology. 2010;257:624-640. [PMID: 21084414 DOI: 10.1148/radiol.10081490] [Cited by in Crossref: 58] [Cited by in F6Publishing: 39] [Article Influence: 5.8] [Reference Citation Analysis]
79 Park WH, Shim JH, Han SB, Won HJ, Shin YM, Kim KM, Lim YS, Lee HC. Clinical utility of des-γ-carboxyprothrombin kinetics as a complement to radiologic response in patients with hepatocellular carcinoma undergoing transarterial chemoembolization. J Vasc Interv Radiol 2012;23:927-36. [PMID: 22633621 DOI: 10.1016/j.jvir.2012.04.021] [Cited by in Crossref: 9] [Cited by in F6Publishing: 8] [Article Influence: 1.0] [Reference Citation Analysis]
80 Choi GH, Shim JH, Kim MJ, Ryu MH, Ryoo BY, Kang YK, Shin YM, Kim KM, Lim YS, Lee HC. Sorafenib alone versus sorafenib combined with transarterial chemoembolization for advanced-stage hepatocellular carcinoma: results of propensity score analyses. Radiology. 2013;269:603-611. [PMID: 23864102 DOI: 10.1148/radiol.13130150] [Cited by in Crossref: 75] [Cited by in F6Publishing: 80] [Article Influence: 9.4] [Reference Citation Analysis]
81 Kan Z, Wright K, Wallace S. Ethiodized oil emulsions in hepatic microcirculation: In vivo microscopy in animal models. Academic Radiology 1997;4:275-82. [DOI: 10.1016/s1076-6332(97)80029-3] [Cited by in Crossref: 32] [Cited by in F6Publishing: 7] [Article Influence: 1.3] [Reference Citation Analysis]
82 Kim HK, Chung Y, Song B, Yang SH, Yoon H, Yu E, Sung K, Lee YS, Lee SG, Suh DJ. Ischemic Bile Duct Injury as a Serious Complication After Transarterial Chemoembolization in Patients with Hepatocellular Carcinoma: . Journal of Clinical Gastroenterology 2001;32:423-7. [DOI: 10.1097/00004836-200105000-00013] [Cited by in Crossref: 76] [Cited by in F6Publishing: 61] [Article Influence: 3.8] [Reference Citation Analysis]
83 Guan YS, Hu Y, Liu Y. Multidetector-row computed tomography in the management of hepatocellular carcinoma with transcatheter arterial chemoembolization. J Gastroenterol Hepatol 2006;21:941-6. [PMID: 16724976 DOI: 10.1111/j.1440-1746.2006.04474.x] [Cited by in Crossref: 7] [Cited by in F6Publishing: 5] [Article Influence: 0.5] [Reference Citation Analysis]
84 Kim JH, Sinn DH, Shin SW, Cho SK, Kang W, Gwak GY, Paik YH, Lee JH, Koh KC, Paik SW, Choi MS. The role of scheduled second TACE in early-stage hepatocellular carcinoma with complete response to initial TACE. Clin Mol Hepatol 2017;23:42-50. [PMID: 28263954 DOI: 10.3350/cmh.2016.0058] [Cited by in Crossref: 6] [Cited by in F6Publishing: 4] [Article Influence: 1.5] [Reference Citation Analysis]
85 Farraher SW, Jara H, Chang KJ, Hou A, Soto JA. Liver and Spleen Volumetry with Quantitative MR Imaging and Dual-Space Clustering Segmentation. Radiology 2005;237:322-8. [DOI: 10.1148/radiol.2371041416] [Cited by in Crossref: 54] [Cited by in F6Publishing: 46] [Article Influence: 3.4] [Reference Citation Analysis]
86 Yan FH, Zhou KR, Cheng JM, Wang JH, Yan ZP, Da RR, Fan J, Ji Y. Role and limitation of FMPSPGR dynamic contrast scanning in the follow-up of patients with hepatocellular carcinoma treated by TACE. World J Gastroenterol. 2002;8:658-662. [PMID: 12174374 DOI: 10.3748/wjg.v8.i4.658] [Cited by in CrossRef: 17] [Cited by in F6Publishing: 14] [Article Influence: 0.9] [Reference Citation Analysis]
87 Bhattacharya S, Novell JR, Winslet MC, Hobbs KEF. Iodized oil in the treatment of hepatocellular carcinoma. British Journal of Surgery 1994;81:1563-71. [DOI: 10.1002/bjs.1800811105] [Cited by in Crossref: 55] [Cited by in F6Publishing: 43] [Article Influence: 3.4] [Reference Citation Analysis]
88 Pavone P, Castrucci M, Catalano C, Marsili L, Petroni GA, Sanvito S, Salviani M. Effect of treatment on clinical trials: Chemoembolization. J Surg Oncol 1993;53:87-90. [DOI: 10.1002/jso.2930530524] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 0.1] [Reference Citation Analysis]
89 Watanabe Y, Ogawa M, Kumagawa M, Hirayama M, Miura T, Matsumoto N, Nakagawara H, Yamamoto T, Moriyama M. Utility of Contrast-Enhanced Ultrasound for Early Therapeutic Evaluation of Hepatocellular Carcinoma After Transcatheter Arterial Chemoembolization. J Ultrasound Med 2020;39:431-40. [PMID: 31436341 DOI: 10.1002/jum.15118] [Cited by in Crossref: 3] [Cited by in F6Publishing: 1] [Article Influence: 1.5] [Reference Citation Analysis]
90 Catalano O, Esposito M, Lobianco R, Cusati B, Altei F, Siani A. Hepatocellular carcinoma treated with chemoembolization: assessment with contrast-enhanced doppler ultrasonography. Cardiovasc Intervent Radiol. 1999;22:486-492. [PMID: 10556408 DOI: 10.1007/s002709900437] [Cited by in Crossref: 17] [Cited by in F6Publishing: 15] [Article Influence: 0.8] [Reference Citation Analysis]
91 Kim KA, Choi SY, Kim MU, Baek SY, Park SH, Yoo K, Kim TH, Kim HY. The Efficacy of Cone-Beam CT–Based Liver Perfusion Mapping to Predict Initial Response of Hepatocellular Carcinoma to Transarterial Chemoembolization. Journal of Vascular and Interventional Radiology 2019;30:358-69. [DOI: 10.1016/j.jvir.2018.10.002] [Cited by in Crossref: 9] [Cited by in F6Publishing: 7] [Article Influence: 4.5] [Reference Citation Analysis]
92 Kwan SW, Fidelman N, Ma E, Kerlan RK Jr, Yao FY. Imaging predictors of the response to transarterial chemoembolization in patients with hepatocellular carcinoma: a radiological-pathological correlation. Liver Transpl. 2012;18:727-736. [PMID: 22344899 DOI: 10.1002/lt.23413] [Cited by in Crossref: 74] [Cited by in F6Publishing: 70] [Article Influence: 8.2] [Reference Citation Analysis]
93 Vossen JA, Kamel IR, Buijs M, Liapi E, Georgiades CS, Hong K, Geschwind JH. Role of Functional Magnetic Resonance Imaging in Assessing Metastatic Leiomyosarcoma Response to Chemoembolization: . Journal of Computer Assisted Tomography 2008;32:347-52. [DOI: 10.1097/rct.0b013e318134ecd6] [Cited by in Crossref: 17] [Cited by in F6Publishing: 4] [Article Influence: 1.3] [Reference Citation Analysis]
94 Kamel IR, Bluemke DA. Imaging Evaluation of Hepatocellular Carcinoma. Journal of Vascular and Interventional Radiology 2002;13:S173-83. [DOI: 10.1016/s1051-0443(07)61784-9] [Cited by in Crossref: 22] [Cited by in F6Publishing: 3] [Article Influence: 1.2] [Reference Citation Analysis]
95 Koda M, Murawaki Y, Mitsuda A, Oyama K, Okamoto K, Idobe Y, Suou T, Kawasaki H. Combination therapy with transcatheter arterial chemoembolization and percutaneous ethanol injection compared with percutaneous ethanol injection alone for patients with small hepatocellular carcinoma: A randomized control study. Cancer 2001;92:1516-24. [DOI: 10.1002/1097-0142(20010915)92:6<1516::aid-cncr1477>3.0.co;2-i] [Cited by in Crossref: 104] [Cited by in F6Publishing: 35] [Article Influence: 5.2] [Reference Citation Analysis]
96 Onishi H, Murakami T, Nakamura H. Diagnosis of Hepatocellular Carcinoma: Multidetector-Row Computed Tomography and Magnetic Resonance Imaging. In: Hayat MA, editor. Liver Cancer. Dordrecht: Springer Netherlands; 2009. pp. 221-35. [DOI: 10.1007/978-1-4020-9804-8_16] [Cited by in Crossref: 1] [Article Influence: 0.1] [Reference Citation Analysis]
97 Solinas A, D'agostino HB, Barzi F, Mosca S, Corneli P, Distrutti E, Caprino G, Morelli A, Wollman B. Percutaneous management of hepatocellular carcinoma: Patient selection for percutaneous alcohol injection alone or combined with arterial chemoembolization. Minimally Invasive Therapy & Allied Technologies 2009;6:65-70. [DOI: 10.3109/13645709709152827] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.1] [Reference Citation Analysis]
98 Guan YS, Zheng XH, Zhou XP, Huang J, Sun L, Chen X, Li X, He Q. Multidetector CT in evaluating blood supply of hepatocellular carcinoma after transcatheter arterial chemoembolization. World J Gastroenterol 2004;10:2127-9. [PMID: 15237450 DOI: 10.3748/wjg.v10.i14.2127] [Cited by in CrossRef: 16] [Cited by in F6Publishing: 11] [Article Influence: 0.9] [Reference Citation Analysis]
99 Golowa YS, Cynamon J, Reinus JF, Kinkhabwala M, Abrams M, Jagust M, Chernyak V, Kaubisch A. Value of noncontrast CT immediately after transarterial chemoembolization of hepatocellular carcinoma with drug-eluting beads. J Vasc Interv Radiol. 2012;23:1031-1035. [PMID: 22739645 DOI: 10.1016/j.jvir.2012.04.020] [Cited by in Crossref: 21] [Cited by in F6Publishing: 17] [Article Influence: 2.3] [Reference Citation Analysis]
100 Choi SJ, Kim J, Seo J, Kim HS, Lee JM, Park H. Parametric response mapping of dynamic CT as an imaging biomarker to distinguish viability of hepatocellular carcinoma treated with transcatheter arterial chemoembolization. Abdom Imaging 2014;39:518-25. [PMID: 24519566 DOI: 10.1007/s00261-014-0087-z] [Cited by in Crossref: 8] [Cited by in F6Publishing: 5] [Article Influence: 1.3] [Reference Citation Analysis]
101 Kim SJ, Choi MS, Kang JY, Choi DI, Park CK, Gwak GY, Lee JH, Koh KC, Paik SW, Yoo BC. Prediction of complete necrosis of hepatocellular carcinoma treated with transarterial chemoembolization prior to liver transplantation. Gut Liver 2009;3:285-91. [PMID: 20431762 DOI: 10.5009/gnl.2009.3.4.285] [Cited by in Crossref: 14] [Cited by in F6Publishing: 12] [Article Influence: 1.2] [Reference Citation Analysis]
102 Miki I, Murata S, Uchiyama F, Yasui D, Ueda T, Sugihara F, Saito H, Yamaguchi H, Murakami R, Kawamoto C, Uchida E, Kumita SI. Evaluation of the relationship between hepatocellular carcinoma location and transarterial chemoembolization efficacy. World J Gastroenterol 2017;23:6437-47. [PMID: 29085193 DOI: 10.3748/wjg.v23.i35.6437] [Cited by in CrossRef: 3] [Cited by in F6Publishing: 2] [Article Influence: 1.0] [Reference Citation Analysis]
103 Fujita T, Ito K, Tanabe M, Yamatogi S, Sasai H, Matsunaga N. Iodized oil accumulation in hypervascular hepatocellular carcinoma after transcatheter arterial chemoembolization: comparison of imaging findings with CT during hepatic arteriography. J Vasc Interv Radiol. 2008;19:333-341. [PMID: 18295691 DOI: 10.1016/j.jvir.2007.10.020] [Cited by in Crossref: 18] [Cited by in F6Publishing: 15] [Article Influence: 1.4] [Reference Citation Analysis]
104 Kim SH, Lee WJ, Lim HK, Lim JH. Prediction of viable tumor in hepatocellular carcinoma treated with transcatheter arterial chemoembolization: usefulness of attenuation value measurement at quadruple-phase helical computed tomography. J Comput Assist Tomogr. 2007;31:198-203. [PMID: 17414753 DOI: 10.1097/01.rct.0000236424.20514.2e] [Cited by in Crossref: 26] [Cited by in F6Publishing: 21] [Article Influence: 1.9] [Reference Citation Analysis]
105 Shima T, Mizuno M, Otsuji H, Mizuno C, Obata H, Park H, Nakajo S, Okanoue T. Evaluation of transcatheter arterial embolization therapy on hepatocellular carcinomas using contrast-enhanced harmonic power Doppler sonography: comparison with CT, power Doppler sonography, and dynamic MRI. J Med Ultrason (2001) 2005;32:107-13. [PMID: 27277266 DOI: 10.1007/s10396-005-0045-z] [Cited by in Crossref: 2] [Cited by in F6Publishing: 1] [Article Influence: 0.4] [Reference Citation Analysis]
106 Hong SW, Lee WY, Chang YG, Lee B, Lee HK, Kim HK. Inflammatory myofibroblastic tumor mimicking hepatocellular carcinoma with dense lipiodol uptake. J Korean Surg Soc 2013;85:89-92. [PMID: 23908967 DOI: 10.4174/jkss.2013.85.2.89] [Cited by in Crossref: 2] [Cited by in F6Publishing: 1] [Article Influence: 0.3] [Reference Citation Analysis]
107 Jin YJ, Chung YH, Kim JA, Park W, Lee D, Shim JH, Lee D, Kim KM, Lim YS, Lee HC. Predisposing factors of hepatocellular carcinoma recurrence following complete remission in response to transarterial chemoembolization. Dig Dis Sci. 2013;58:1758-1765. [PMID: 23361574 DOI: 10.1007/s10620-013-2562-8] [Cited by in Crossref: 14] [Cited by in F6Publishing: 14] [Article Influence: 1.8] [Reference Citation Analysis]
108 Tsui EY, Chan JH, Cheung YK, Cheung CC, Tsui WC, Szeto ML, Lau KW, Yuen MK, Luk SH. Evaluation of therapeutic effectiveness of transarterial chemoembolization for hepatocellular carcinoma: correlation of dynamic susceptibility contrast-enhanced echoplanar imaging and hepatic angiography. Clin Imaging. 2000;24:210-216. [PMID: 11274885 DOI: 10.1016/s0899-7071(00)00204-7] [Cited by in Crossref: 14] [Cited by in F6Publishing: 8] [Article Influence: 0.7] [Reference Citation Analysis]
109 Hieda M, Toyota N, Kakizawa H, Hirai N, Tachikake T, Matsuura N, Ishikawa M, Ito K. Evaluation of Hepatocellular Carcinoma Supplied by the Right Inferior Phrenic Artery at Initial Treatment: . Journal of Computer Assisted Tomography 2008;32:877-81. [DOI: 10.1097/rct.0b013e31815d9b1b] [Cited by in Crossref: 3] [Article Influence: 0.2] [Reference Citation Analysis]
110 Qian J, Vossoughi D, Woitaschek D, Oppermann E, Bechstein WO, Li WY, Feng GS, Vogl T. Combined transarterial chemoembolization and arterial administration of Bletilla striata in treatment of liver tumor in rats. World J Gastroenterol 2003;9:2676-80. [PMID: 14669311 DOI: 10.3748/wjg.v9.i12.2676] [Cited by in CrossRef: 22] [Cited by in F6Publishing: 11] [Article Influence: 1.3] [Reference Citation Analysis]
111 Wen YL, Kudo M, Zheng RQ, Minami Y, Chung H, Suetomi Y, Onda H, Kitano M, Kawasaki T, Maekawa K. Radiofrequency ablation of hepatocellular carcinoma: therapeutic response using contrast-enhanced coded phase-inversion harmonic sonography. AJR Am J Roentgenol. 2003;181:57-63. [PMID: 12818830 DOI: 10.2214/ajr.181.1.1810057] [Cited by in Crossref: 77] [Cited by in F6Publishing: 66] [Article Influence: 4.3] [Reference Citation Analysis]
112 Huang J, Pan H, Chou C, Liang H, Yeh L, Yang T, Liu S. Optimizing Scanning Phases in Detecting Small (<2 cm) Hepatocellular Carcinoma: Whole-Liver Dynamic Study With Multidetector Row CT. Journal of Computer Assisted Tomography 2008;32:341-6. [DOI: 10.1097/rct.0b013e318123e85a] [Cited by in Crossref: 11] [Cited by in F6Publishing: 2] [Article Influence: 0.8] [Reference Citation Analysis]
113 Pacella CM, Bizzarri G, Cecconi P, Caspani B, Magnolfi F, Bianchini A, Anelli V, Pacella S, Rossi Z. Hepatocellular Carcinoma: Long-term Results of Combined Treatment with Laser Thermal Ablation and Transcatheter Arterial Chemoembolization. Radiology 2001;219:669-78. [DOI: 10.1148/radiology.219.3.r01ma02669] [Cited by in Crossref: 87] [Cited by in F6Publishing: 70] [Article Influence: 4.4] [Reference Citation Analysis]
114 Planz VB, Lubner MG, Pickhardt PJ. Volumetric analysis at abdominal CT: oncologic and non-oncologic applications. Br J Radiol 2019;92:20180631. [PMID: 30457881 DOI: 10.1259/bjr.20180631] [Cited by in Crossref: 5] [Cited by in F6Publishing: 2] [Article Influence: 1.7] [Reference Citation Analysis]
115 Trinchet J, Beaugrand M. Treatment of hepatocellular carcinoma in patients with cirrhosis. Journal of Hepatology 1997;27:756-65. [DOI: 10.1016/s0168-8278(97)80095-5] [Cited by in Crossref: 44] [Cited by in F6Publishing: 8] [Article Influence: 1.8] [Reference Citation Analysis]